This compound is a boronic ester pharmaceutical intermediate featuring a piperidine ring substituted with a trifluoroethyl group. It is primarily used as a building block in the synthesis of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1219931-41-5
3,6-Dihydro-2H-pyran-4-boronic acid pinacol ester
boronic ester pharmaceutical intermediate
4-Nitrobenzoyl chloride
Intermediate for dyes and chemicals
N,N'-Dibenzylethylenediamine diacetate
pharmaceutical intermediate
N-(4-Ethoxyphenyl)-3-oxobutanamide
pharmaceutical intermediate
2,2-bis(3-amino-4-hydroxylphenyl)propane
pharmaceutical intermediate
1-Methyl-1,2,3,6-tetrahydropyridine-4-boronic acid, pinacol ester
boronic ester research reagent
1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydropyridin-1(2H)-yl)ethan-1-one
Boronic ester protecting group reagent
Tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine-1-carboxylate
Pharmaceutical intermediate for API synthesis
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-3,6-dihydro-2H-pyridine
UFKUKPYUIMQHQV-UHFFFAOYSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CCN(CC2)CC(F)(F)F
—